Author

Jun Kang

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Clinical characteristics of metabolic dysfunction-associated steatotic liver disease and its association with significant liver fibrosis in hospitalized patients with chronic hepatitis B: a single-center retrospective cross-sectional study

Coexistence of chronic hepatitis B (CHB) and metabolic dysfunction-associated steatotic liver disease (MASLD) is becoming more common in clinical settings, but the relationship between MASLD and significant liver fibrosis in CHB remains uncertain. To delineate the clinical profile of hospitalized CHB patients with conc...

Chun-Xia Wang, Jun Kang, Jia-Wei Zhang et al. · BMC Gastroenterology · 0 citations

Review Open access Oct 2026

Global research trends and emerging themes of ketamine in perioperative neurocognitive disorders: a bibliometric analysis

Within the contemporary perioperative neurocognitive disorder (PND) framework, postoperative neurocognitive outcomes include postoperative delirium, delayed neurocognitive recovery, and postoperative neurocognitive disorder. Interest in ketamine and its enantiomers has increased, but the clinical literature on peri...

Jun Kang, Zi-Wei Wang, Jia-Xuan Bi et al. · Frontiers in Medicine · 0 citations

Review Open access Oct 2026

Dexmedetomidine as a potential neuroprotective agent against Alzheimer’s disease: molecular mechanisms and therapeutic perspectives

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by extracellular deposition of amyloid-β (Aβ), intracellular hyperphosphorylation of microtubule-associated protein tau and chronic neuroinflammation. At present, effective disease-modifying therapies for AD remain limited. Dexmedetomidine (Dex),...

Jun Kang, Yong-Bo Duan, Jia-Xuan Bi et al. · Frontiers in Aging Neuroscie... · 0 citations